Ercan Varol

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: an updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials

The safety of statins in clinical practice

Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion

Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation

Fish Oil and Postoperative Atrial Fibrillation

The Generation R Study: design and cohort update 2010

Molecular mechanisms of fluoride toxicity

Biologics and heart failure in rheumatoid arthritis: are we any wiser?

Statins for prevention of atrial fibrillation after cardiac surgery: A systematic literature review

Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities

ROS Function in Redox Signaling and Oxidative Stress

Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Statin use and development of atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials and observational studies

The role of antioxidants in the chemistry of oxidative stress: A review

Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review

Prevention of Postoperative Atrial Fibrillation: Novel and Safe Strategy Based on the Modulation of the Antioxidant System

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

First-Trimester Prediction of Preeclampsia in Nulliparous Women at Low Risk

Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study

New and Emerging Biomarkers in Left Ventricular Systolic Dysfunction—Insight into Dilated Cardiomyopathy

Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis

Disordered haematopoiesis and athero-thrombosis

Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Antioxidant Vitamins in the Prevention of Atrial Fibrillation: What Is the Evidence?

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

N-acetylcysteine for sepsis and systemic inflammatory response in adults

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Hypertensive Disorders of Pregnancy

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

Effect of Atorvastatin on the Recurrence Rates of Atrial Fibrillation After Electrical Cardioversion

Statin Use before By-Pass Surgery Decreases the Incidence and Shortens the Duration of Postoperative Atrial Fibrillation

Aortic Elasticity is Impaired in Patients with Endemic Fluorosis

N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study

Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study

Mean platelet volume is associated with insulin resistance in non-obese, non-diabetic patients with coronary artery disease

Effect of renin–angiotensin aldosteron system blockers on postoperative atrial fibrillation

Effects of Morning Versus Evening Intake of Atorvastatin on Major Cardiac Event and Restenosis Rates in Patients Undergoing First Elective Percutaneous Coronary Intervention

Relationship between cytokines and tumour markers in patients with chronic heart failure

Mean Platelet Volume is Elevated in Patients With Low High-Density Lipoprotein Cholesterol

N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study

Low High-Density Lipoprotein Cholesterol Is Characterized by Elevated Oxidative Stress

Increased Mean Platelet Volume in Patients With Aortic Stenosis

Mean platelet volume in patients with prehypertension and hypertension